FDA Drug Application (203820) for REPAGLINIDE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number203820
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameREPAGLINIDE
Active IngredientREPAGLINIDE

Active IngredientCount
List of drugs with Active Ingredient REPAGLINIDE4


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD